… The aim of this study was to assess whether lesion heterogeneity through pixel-by-pixel
analysis of contrast-enhanced MR parameter maps would improve breast lesion differentiation. …

… benign and malignant lesions in the amplitude of uptake (P = … basic assumptions and the
limitations of describing GdDTPA … which the plasma concentration of GdDTPA is derived from a …

… Differentiation of Gd-DTPA enhancement in dynamic MR of breast carciof benign from
malignant breast masses by time-intensity eval- noma. Fortschr Rontgenstr 1994; 160:518–523. …

… breast tissue. In 25 patients, dynamic studies were performed at short intervals after the
injection of contrast medium in an attempt to differentiate more reliably between breast … lesions …

… breast lesions, with malignant lesions demonstrating more rapid uptake of contrast than benign
lesions… Radiation fibrosis: differentiation from recurrent tumour by MR imaging. Radiology …

… We interpreted a total of 13 liver metastatic lesions in nine breast cancer patients which …
be a distinguishing feature for differentiation between breast and colon cancer liver metastases. …

… for Gd-DTPA signal enhancement (8), first developed for blood-brain barrier lesions studied
… Uptake was slower than in the breast tumors we studied, reaching its maximum at 7-15 min. …

… quent to enhancement from uptake of Gd-DTPA is preferred (… the breast immediately after
the administration of GdDTPA to … MFU in differentiating benign from malignant breast tumors, …

… gadolinium-diethylenetriamine penta-acetic acid (GdDTPA) followed by T1-weighted MFU
can improve detection of breast … Dynamic studies of gadolinium uptake in brain tumors using …

… all 66 patients with 75 lesions and in 64 patients with 73 lesions, respectively. MR … uptake
to differentiate benign from malignant lesions. Histopathologic proof was obtained in 63 lesions…